James K. Blodgett
James K. Blodgett publishes mostly in Molecular Biology, Oncology and Organic Chemistry, on topics such as Chemical Synthesis and Analysis, Peptidase Inhibition and Analysis and Coagulation, Bradykinin, Polyphosphates, and Angioedema.
- World rank
- #3,245,158 of 7,710,434 ranked researchers
- Rank in United States
- #919,996 of 1,627,098
- Works
- 16
- Citations
- 758
- Citations per work
- 47.4
What does James K. Blodgett research?
James K. Blodgett's work is mostly in Medicine (36%), Biochemistry, Genetics and Molecular Biology (24%), Chemistry (11%).
Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.
The fields and subfields, with their numbers
- Health Sciences635.6%
- Medicine635.6%
- Everything else528.9%
- Life Sciences424.4%
- Physical Sciences211.1%
- Chemistry211.1%
- 1Molecular Biology24% of their works
- 2Oncology13% of their works
- 3Organic Chemistry11% of their works
- 4Genetics9% of their works
- 5Hematology7% of their works
- 6Radiology, Nuclear Medicine and Imaging7% of their works
Research topics
- Chemical Synthesis and Analysis
- Peptidase Inhibition and Analysis
- Coagulation, Bradykinin, Polyphosphates, and Angioedema
- Monoclonal and Polyclonal Antibodies Research
- Blood Coagulation and Thrombosis Mechanisms
- Systemic Lupus Erythematosus Research
- Beetle Biology and Toxicology Studies
- Venomous Animal Envenomation and Studies
Which keywords describe James K. Blodgett's research?
The keywords of their largest research topics: Drug Discovery, Peptide Synthesis, Fibroblast Activation Protein, Tumor Microenvironment, Hereditary Angioedema, Kinin Receptor Family, Fc Receptors and Hemostasis.
- Protein Phosphatase Inhibitors
- Cantharidin
- Systemic Lupus Erythematosus
- Antiphospholipid Syndrome
- Hemostasis
- Kinin Receptor Family
- Tumor Microenvironment
- Peptide Synthesis
- Drug Discovery
- Fibroblast Activation Protein
- Hereditary Angioedema
- Fc Receptors
- Therapeutic Antibodies
- Protease-Activated Receptors
- Thrombin
- Envenoming
- Snake Venom
Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.
All 17 words, with their numbers
- Drug Discovery71 topic
- Peptide Synthesis71 topic
- Fibroblast Activation Protein61 topic
- Tumor Microenvironment61 topic
- Hereditary Angioedema41 topic
- Kinin Receptor Family41 topic
- Fc Receptors31 topic
- Hemostasis32 topics
- Therapeutic Antibodies31 topic
- Antiphospholipid Syndrome21 topic
- Protease-Activated Receptors21 topic
- Systemic Lupus Erythematosus21 topic
- Thrombin21 topic
- Cantharidin11 topic
- Envenoming11 topic
- Protein Phosphatase Inhibitors11 topic
- Snake Venom11 topic
Where does James K. Blodgett work?
James K. Blodgett's main affiliation in the publication record is Cortech Solutions (United States), United States.
How many publications and citations does James K. Blodgett have?
OpenAlex counts 16 works and 758 citations for James K. Blodgett, an h-index of 9, ranking #3,245,158 of 7,710,434 researchers worldwide on the quality score.
Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.
Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.
Discussion
Ask a question or share a note about James K. Blodgett. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.